|
Mr. Vaughan most recently consulted on business development and strategy for Chiron Corporation. He served as vice president, corporate & business development, at Saegis Pharmaceuticals where he actively participated in the successful venture financing and worked with large pharmaceutical companies to in-license the company's lead development compounds and form development alliances. Before Saegis, as director, marketing & business development at Inhale Therapeutics (now Nektar), he led product marketing and worked in business development and alliance management roles. From 1995 to 1997, he worked in international marketing and new business development for Boehringer-Mannheim Corporation and then assisted in the successful divestiture of a key business unit as part of the acquisition of the company by Roche. Mr. Vaughan received a BS in biochemistry from the University of California, Davis, and an MBA from the Leavey School of Business, Santa Clara University. | 